Big Chemical Encyclopedia

Chemical substances, components, reactions, process design ...

Articles Figures Tables About

Enzyme disease

The diagnostic usefulness should be established by appropriate retrospective or prospective studies to see if the test in fact improves the diagnostic accuracy. For inherited enzyme diseases, the measurement of the enzyme activity can be diagnostically specific and highly useful. For otherwise obvious diseases such as metastatic prostatic carcinoma, enzyme tests may be of little value (24). [Pg.187]

The hepatic clearance of drugs with an intermediate extraction ratio (Eh, 0.3-0.6) is affected by all three physiological variables blood flow to the liver, the unbound fraction in blood and the activity of hepatic drug-metabolizing enzymes. Disease-induced changes in the disposition of these drugs is least predictable. [Pg.107]

Abnormalities of porphyrin metabolism are caused by inherited defects in the genes of the biosynthetic pathway enzymes, diseases called the porphyrias, or by conditions (e.g., lead toxicity) that affect the enzymatic activity in subjects with normal heme synthesis genes. [Pg.1214]

C. Excreted in the urine in the rare hereditary disease alkaptonuria. Homogentisic acid is easily oxidized in the air to dark-coloured polymeric products, so that urine from patients with alkaptonuria turns gradually black. It is formed from tyrosine and is an intermediate in tyrosine breakdown in the body. Alkaptonuria is due to the absence of the liver enzyme which cleaves the aromatic ring. [Pg.205]

The process of target identification analyzes a complex disease process by dissecting it into its fundamental components. This makes it possible to identify the one that is most integral to the manifestation of the disease. Target identification aims to understand the biological processes related to a disease, and to identify its mechanism and the structure of individual elements of the disease. Commonly these individual elements are receptors, enzymes, etc., which become the target of new drugs. [Pg.600]

Phenylpyruvic acid can cause mental retardation m infants who are deficient m the enzymes necessary to convert l phenylalanine to l tyrosine This disorder is called phenylketonuria, or PKU disease PKU disease can be detected by a simple test rou tmely administered to newborns It cannot be cured but is controlled by restricting the dietary intake of l phenylalanine In practice this means avoiding foods such as meat that are rich m l phenylalanine... [Pg.1125]

Synthesis. Histamine [51-45-6] 2-(4-imidazolyl)ethylarnine (1) is formed by decarboxylation of histidine by the enzyme L-histidine decarboxylase (Fig. 1). Most histamine is stored preformed in cytoplasmic granules of mast cells and basophils. In humans mast cells are found in the loose connective tissue of all organs, especially around blood and lymphatic vessels and nerves. These cells are most abundant in the organs expressing allergic diseases the skin, respiratory tract, and gastrointestinal tract. [Pg.135]

As the result of high specificity and sensitivity, nucleic acid probes are in direct competition with immunoassay for the analytes of some types of clinical analytes, such as infectious disease testing. Assays are being developed, however, that combine both probe and immunoassay technology. In such hybrid probe—immunoassays, the immunoassay portion detects and amplifies the specific binding of the probe to a nucleic acid. Either the probe per se or probe labeled with a specific compound is detected by the antibody, which in turn is labeled with an enzyme or fluorophore that serves as the basis for detection. [Pg.28]

Assay of Enzymes In body fluids, enzyme levels aie measured to help in diagnosis and for monitoiing treatment of disease. Some enzymes or isoenzymes are predominant only in a particular tissue. When such tissues are damaged because of a disease, these enzymes or isoenzymes are Hberated and there is an increase in the level of the enzyme in the semm. Enzyme levels are deterrnined by the kinetic methods described, ie, the assays are set up so that the enzyme concentration is rate-limiting. The continuous flow analyzers, introduced in the early 1960s, solved the problem of the high workload of clinical laboratories. In this method, reaction velocity is measured rapidly the change in absorbance may be very small, but within the capabiUty of advanced kinetic analyzers. [Pg.40]

The development of easy-to-use assays for determining theophylline blood levels afforded a handle on maintenance of effective but nontoxic levels. The relatively good availabihty of such assays in the United States probably contributed to the historical preference for theophylline treatment by U.S. physicians. Careful titration of the dose must be done on a patient-by-patient basis because individual rates of metaboHsm vary widely. Most ( 85%) of an oral dose of theophylline is metabolized by Hver microsomal enzymes. As a result many dmgs, eg, cimetidine [51481-61-9], anticonvulsants, or conditions, eg, fever, cigarette smoking, Hver disease, which affect Hver function alter theophylline blood levels. [Pg.440]

In 1956 selenium was identified (123) as an essential micronutrient iu nutrition. In conjunction with vitamin E, selenium is effective iu the prevention of muscular dystrophy iu animals. Sodium selenite is adrninistered to prevent exudative diathesis iu chicks, a condition iu which fluid leaks out of the tissues white muscle disease iu sheep and infertility iu ewes (see Eeed ADDITIVES). Selenium lessens the iacidence of pneumonia iu lambs and of premature, weak, and stillborn calves controls hepatosis dietetica iu pigs and decreases muscular inflammation iu horses. White muscle disease, widespread iu sheep and cattle of the selenium-deficient areas of New Zealand and the United States, is insignificant iu high selenium soil areas. The supplementation of animal feeds with selenium was approved by the U.S. EDA iu 1974 (see Eeed additives). Much of selenium s metaboHc activity results from its involvement iu the selenoproteia enzyme, glutathione peroxidase. [Pg.337]

Disease States. Rickets is the most common disease associated with vitamin D deficiency. Many other disease states have been shown to be related to vitamin D. These can iavolve a lack of the vitamin, deficient synthesis of the metaboUtes from the vitamin, deficient control mechanisms, or defective organ receptors. The control of calcium and phosphoms is essential ia the maintenance of normal cellular biochemistry, eg, muscle contraction, nerve conduction, and enzyme function. The vitamin D metaboUtes also have a function ia cell proliferation. They iateract with other factors and receptors to regulate gene transcription. [Pg.139]

Fig. 8. Plot of data from patients having Hver diseases A or B or unknown X (a) on two blood enzymes (b) scores of points on the first two eigenvectors obtained from an eight-dimensional enzyme space and (c) eigenvector plot of the variance weighted data. Variance weights ranged from 3.5 to 1.2 for the eight blood enzymes measured. A weight of 1.0 indicates no discrimination information (22). Fig. 8. Plot of data from patients having Hver diseases A or B or unknown X (a) on two blood enzymes (b) scores of points on the first two eigenvectors obtained from an eight-dimensional enzyme space and (c) eigenvector plot of the variance weighted data. Variance weights ranged from 3.5 to 1.2 for the eight blood enzymes measured. A weight of 1.0 indicates no discrimination information (22).
Thrombolytic Enzymes. Although atherosclerosis and the accompanying vascular wall defects are ultimately responsible for such diseases as acute pulmonary embolism, arterial occlusion, and myocardial infarction, the lack of blood flow caused by a fibrin clot directly results in tissue injury and in the clinical symptoms of these devastating diseases (54). Thrombolytic enzyme therapy removes the fibrin clot by dissolution, and has shown promise in the treatment of a number of thrombo-occlusive diseases (60). [Pg.309]

The proteolytic enzymes, trypsin, chymotrypsin, and chymoral [8076-22-0] in combination, have been used for the treatment of post-operative hand trauma, athletic injuries, and sciatica (214—216). Trypsin has also been used successfully in treating hyaline membrane disease of newborn babies, a condition usually fatal without treatment (217). Immobilized preparations of trypsin are useful in treating acute radiation cystitis following pelvic x-irradiation therapy (218). [Pg.312]

One limitation of enzyme replacement therapy is the targeting of enzyme proteins to appropriate sites of substrate accumulation. Administration of a cholesterol esterase conjugated to albumin results in the degradation of pathologic cholesterol ester accumulations within the lysosomes of fibroblasts from a patient with cholesterol ester storage disease (246). [Pg.312]

Another class of therapeutic agents is used for the treatment of certain genetic diseases or other enzymatic disorders caused by the dysfunction or absence of one particular enzyme. This often leads to an unwanted accumulation or imbalance of metaboUtes in the organism. Eor example, some anticonvulsive agents are inhibitors for y-aminobutyric acid aminotransferase [9037-67-6]. An imbalance of two neurotransmitters, glutamate and y-aminobutyric acid, is responsible for the symptoms. Inhibition of the enzyme leads to an increase of its substrate y-aminobutyric acid, decreasing the imbalance and subsequently relieving the symptoms of the disease. [Pg.318]


See other pages where Enzyme disease is mentioned: [Pg.538]    [Pg.65]    [Pg.538]    [Pg.65]    [Pg.5]    [Pg.289]    [Pg.334]    [Pg.218]    [Pg.103]    [Pg.198]    [Pg.199]    [Pg.199]    [Pg.229]    [Pg.42]    [Pg.104]    [Pg.518]    [Pg.539]    [Pg.250]    [Pg.432]    [Pg.155]    [Pg.240]    [Pg.23]    [Pg.28]    [Pg.66]    [Pg.244]    [Pg.313]    [Pg.101]    [Pg.422]    [Pg.308]    [Pg.311]    [Pg.313]    [Pg.313]    [Pg.318]    [Pg.318]    [Pg.318]    [Pg.358]   
See also in sourсe #XX -- [ Pg.374 ]




SEARCH



Angiotensin converting enzyme inhibitors hypertensive renal disease

Angiotensin-converting enzyme inhibitors coronary heart disease

Angiotensin-converting enzyme inhibitors renal disease treatment

Cardiovascular disease angiotensin-converting enzyme

Debranching enzyme storage disease

Disease states, profiling enzyme activities

E2 Enzymes and Disease

Enzyme deficiencies, genetic diseases

Enzyme deficiency diseases

Enzyme deficiency diseases Lesch-Nyhan syndrome

Enzyme deficiency diseases glucose-6-phosphate dehydrogenase

Enzyme deficiency diseases glycogen storage disease

Enzyme deficiency diseases homocystinuria

Enzyme deficiency diseases hypoxanthine-guanine

Enzyme deficiency diseases phenylketonuria

Enzyme deficiency diseases phosphoribosyltransferase)

Enzyme induction renal disease

Enzyme-linked immunosorbent disease testing

Enzymes Released from Diseased Liver Tissue

Gaucher disease, enzyme

Gaucher disease, enzyme replacement therapy

Glycogen storage disease branching enzyme deficiency

Glycogen storage disease debranching enzyme deficiency

Liver diseases, enzyme activity

Lysosomal storage diseases enzyme replacement therapies

Mitochondrial diseases respiratory enzymes

Pompe disease, enzyme

Pompe disease, enzyme replacement therapy

Reperfusion diseases/injuries enzymes)

© 2024 chempedia.info